HighTower Advisors’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
CB
HighTower Advisors's CNMD Position: Q4 2025 in Review
HighTower Advisors sold out of CONMED (CNMD) in Q4 2025, closing a stake of 6,273 shares — an estimated $295K sold.
HighTower Advisors first reported a position in CNMD in Q2 2018 and held it in 21 quarters. The position peaked at $3.29M in Q4 2023. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.
- HighTower Advisors reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
- HighTower Advisors sold 6,273 CONMED shares in Q4 2025, an estimated $295K.
- HighTower Advisors first reported a position in CONMED in Q2 2018 and held it in 21 quarters.
- HighTower Advisors's CONMED position peaked at $3.29M in Q4 2023.
- 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.
Based on HighTower Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.